$LRCX

What's Going On With Lam Research Stock Thursday? - Lam Research (NASDAQ:LRCX)

Lam Research (LRCX) shares were mostly flat Thursday as investors weighed technical levels after a strong 12-month run. The stock is consolidating near support around $313 and below the 50-day SMA ($337.50). Lam plans to train about 3,500 students with NY Creates over five years and add ~200 jobs in Singapore. Analysts maintain Buy/Overweight views; average target $384.84.

Original reporting
Published Aug 13, 2026, 1:55 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 5:38 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
What's Going On With Lam Research Stock Thursday? - Lam Research (NASDAQ:LRCX) — source image
Decision brief

The 30-second read

$LRCXBullishLow
01

Why it matters

The operational initiatives (SEMulator3D-based training with NY Creates, Singapore hiring) are supportive for long-term talent and advanced technology execution, but the article’s trading focus is technical: $313 support versus the 50-day SMA near $337.5 resistance.

02

Market read

Traders get a near-term technical roadmap for LRCX (support near $313, resistance near the 50-day SMA) alongside incremental workforce expansion details.

03

What to watch

The article cites a premium valuation (P/E ~56.6) and mixed technical signals (20-day SMA below 50-day), which could cap upside even if the workforce initiatives are positive.

Relevance 4/10Novelty 4/10Timing: Thursday intraday technical watch, with support near $313 and resistance around the 50-day SMA.

Background

Lam Research stock is described as consolidating after a June swing high, with investors watching support and moving-average relationships.

Company-level read

Ticker impact

$LRCXBullishMedium confidence
Context

Lam Research is expanding its semiconductor talent pipeline via a NY Creates program using its SEMulator3D software, plus plans to add about 200 jobs in Singapore.

Expected impact

Likely modest, with traders focusing more on whether LRCX defends the $313 support area and can reclaim the 50-day SMA.

Evidence & confidence

The article provides concrete operational expansion details (training scale, software use, hiring plan) but no immediate financial guidance; the dominant actionable element is the stated technical levels and mixed momentum/RSI readings.

Market effects

Reinforces the broader semiconductor capex and skills pipeline theme, but the article does not quantify demand or orders, limiting sector read-through.

Singapore hiring focus could be read as continued investment in advanced packaging and next-generation memory/photonic work.

Limited global impact beyond reinforcing semiconductor workforce development and advanced-node ecosystem narratives.

Counterpoint

The hiring and training program may not translate into near-term revenue, so technical levels could dominate price action rather than fundamentals.

Key entities

  • Lam Research

    Subject of the article; expanding semiconductor talent pipeline and hiring, while trading in a technical consolidation range.

  • NY Creates

    Training partner for about 3,500 students over five years using Lam’s SEMulator3D virtual fabrication software.

Related articles

$AMATMed

Applied Materials is Down 6% Premarket. Will It Drag Down Lam Research, KLA, and Other Semi Equipment Stocks?

Applied Materials (AMAT) fell about 5.7% premarket after record fiscal Q3 results but guidance for Q4 revenue and margins missed elevated expectations. The company reported record Q3 revenue of $9.1B and non-GAAP EPS of $3.50, and guided Q4 revenue to $10.25B plus or minus $500M and EPS to $4.02 plus or minus $0.20. Lam Research (LRCX) and KLA (KLAC) were little changed premarket.

$CRWVMed

Stocks Trading Higher on Favorable CPI Report and Positive AI News

Stocks rose after a favorable US CPI report, with markets reducing the odds of a 25 bp FOMC hike on Sept. 15-16. Core CPI matched a 5.5-year low. CoreWeave (CRWV) gained on Q3 revenue guidance of $3.45-$3.60B and full-year $12.4-$13.2B. Super Micro (SMCI) rose on better Q3 guidance, lifting chip stocks and SOXX.

$LRCXMedAI 8/10

Lam Research Corp (LRCX) Stock News & Articles

The article discusses ACM Research, a $5.1 billion cleaning-tool maker, and notes its results as a read on whether Chinese fabs are still buying despite export controls. It cites ACM Research Q4 2026 EPS of $1.82 (vs $1.68 est) and revenue of $6.72B (vs $6.67B est). It also mentions read-throughs to Lam Research and Applied Materials, and Lam Research’s guidance for a September-quarter revenue of $8.10B.

$AMATMed

Bernstein raises WFE growth estimates, boosts price targets

Bernstein raised its wafer fabrication equipment (WFE) spending forecasts, citing confidence the semiconductor upcycle will continue. It lifted 2026 WFE to $148B (+26.3% YoY), 2027 to $204B (+32.6%), and 2028 to $259B (+27%). Price targets were increased for Lam Research, KLA, and Applied Materials, plus preferences for Tokyo Electron, Kokusai, and ASML.